Recently Published | The New England Journal of Medicine
2025年1月15日 · The BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New ...
Critical Illness in an Adolescent with Influenza A(H5N1) Virus ...
2024年12月31日 · Influenza A(H5N1) viruses are an emerging zoonotic threat and have spread widely throughout birds in North America. Recently, influenza A(H5N1) infection led to serious illness in a teenager in ...
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Antibiotic Treatment for 7 versus 14 Days in Patients with …
2024年11月20日 · Across 74 hospitals in seven countries, 3608 patients underwent randomization and were included in the intention-to-treat analysis; 1814 patients were assigned to 7 days of antibiotic treatment ...
New England Journal of Medicine
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on a wide variety of topics.
Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in …
2024年12月31日 · Highly pathogenic avian influenza A(H5N1) viruses were first recognized to cause human illnesses in Hong Kong in 1997. As of November 1, 2024, more than 900 human cases in 24 countries had been ...
The Emerging Threat of H5N1 to Human Health | New England …
2024年12月31日 · Against this background, more humans have come into contact with HPAI A(H5N1). Investigators now report in the Journal a series of human cases from the United States and Canada. 2,3 The former ...
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
2024年12月11日 · In a phase 3, open-label trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer that recurred or progressed during or after ...
Tirzepatide for Heart Failure with Preserved Ejection Fraction and ...
2024年11月16日 · A total of 364 patients were assigned to the tirzepatide group and 367 to the placebo group; the median duration of follow-up was 104 weeks. Adjudicated death from cardiovascular causes or a ...
Tirzepatide for Obesity Treatment and Diabetes Prevention
2024年11月13日 · At 176 weeks, the mean percent change in body weight among the participants who received tirzepatide was −12.3% with the 5-mg dose, −18.7% with the 10-mg dose, and −19.7% with the 15-mg dose ...